Rankings
▼
Calendar
MESO Q1 2016 Earnings — Mesoblast Limited Revenue & Financial Results | Market Cap Arena
MESO
Mesoblast Limited
$2B
Q1 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$8M
Gross Profit
$1M
17.4% margin
Operating Income
-$14M
-192.5% margin
Net Income
-$13M
-175.2% margin
EPS (Diluted)
$-0.24
← FY 2016
All Quarters
Q2 2016 →